These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1986740)

  • 1. Inhibition of serine esterases in different rat tissues following inhalation of soman.
    Walday P; Aas P; Fonnum F
    Biochem Pharmacol; 1991 Jan; 41(1):151-3. PubMed ID: 1986740
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver esterases and soman toxicity in the rat following partial hepatectomy.
    Jokanović M
    Biochem Pharmacol; 1990 Feb; 39(4):797-9. PubMed ID: 2306283
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM; Brecht KM; O'Neill BL
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats.
    Aas P; Sterri SH; Hjermstad HP; Fonnum F
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):437-45. PubMed ID: 4035697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esterase activities and soman toxicity in developing rat.
    Sterri SH; Berge G; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):136-40. PubMed ID: 4061089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of soman administration on beta-esterases in blood, liver microsomes and brain regions of rats.
    Purshottam T; Kaveeshwar U
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):197-200. PubMed ID: 1473852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylesterase inhibition and potentiation of soman toxicity.
    Cohen SD
    Arch Toxicol; 1981 Nov; 49(1):105-6. PubMed ID: 7053071
    [No Abstract]   [Full Text] [Related]  

  • 10. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases.
    Grubic Z; Sket D; Brzin M
    Arch Toxicol; 1988; 62(5):398-9. PubMed ID: 3242452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats.
    Maxwell DM; Lenz DE; Groff WA; Kaminskis A; Froehlich HL
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):66-76. PubMed ID: 3564032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of carboxylesterase in protection against soman toxicity.
    Purshottam T; Srivastava R
    Pharmacology; 1989; 38(5):319-26. PubMed ID: 2762374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Feb; 33(4):683-5. PubMed ID: 6704186
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG; Benschop HP; DeJong LP; Wolthuis OL
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected synergism between an alkylating analog of oxotremorine and soman.
    Jenden DJ; Overstreet DH; Booth RA; Russell RW; Rice KM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S78-83. PubMed ID: 4092897
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes.
    Fonnum F; Sterri SH; Aas P; Johnsen H
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S29-38. PubMed ID: 4092894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detoxification of soman in the perfused rat liver: quantitative uptake and stereoisomer metabolism.
    Wahlländer A; Szinicz L
    Arch Toxicol; 1990; 64(7):586-9. PubMed ID: 2073132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
    de Jong LP; van Dijk C
    Biochem Pharmacol; 1984 Feb; 33(4):663-9. PubMed ID: 6704183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.